1
Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:June 25, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:June 25, 2019Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:July 22, 2019Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:August 26, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.